When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Transtornos de pânico

Última revisão: 27 Nov 2025
Última atualização: 01 Oct 2025

Resumo

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presença de fatores de risco
  • início inesperado
  • apreensão e preocupação
  • comportamento de evitação
  • taquicardia
  • resultado positivo para rastreamento do pânico da Avaliação de Transtornos Mentais na Atenção Primária (PRIME-MD)
  • escala de gravidade do transtorno de pânico (EGTP)
  • pontuação de corte do GAD-7 ≥10
Todos los datos

Otros factores de diagnóstico

  • palpitações, dor e desconforto torácicos
  • náuseas e dor abdominal
  • tontura
  • anormalidades das percepções
  • sintomas respiratórios
  • dependência de pistas indicativas de segurança
  • parestesias
  • tremor muscular
  • sudorese
  • desmaios
  • calafrios ou fogachos
Todos los datos

Factores de riesgo

  • história em parentes de primeiro grau
  • idade 18 a 39 anos
  • sexo feminino
  • etnia branca e índios norte-americanos
  • eventos vitais importantes
  • transtornos comórbidos
  • fatores psicológicos
  • asma e variabilidade respiratória
  • tabagismo
  • consumo de cafeína
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • avaliação clínica
Todos los datos

Pruebas diagnósticas que deben considerarse

  • eletrocardiograma (ECG)
  • glicose sanguínea
  • testes da função tireoidiana
  • perfil metabólico
  • análise toxicológica
Todos los datos

Algoritmo de tratamiento

Agudo

ataque de pânico agudo

En curso

transtorno de pânico

ataques de pânico sem transtorno de pânico

Colaboradores

Autores

Craig N. Sawchuk, PhD
Craig N. Sawchuk

Professor

Department of Psychiatry and Psychology

Mayo Clinic

Rochester

MN

Divulgaciones

CNS declares that he has no competing interests.

Jason P. Veitengruber, MD
Jason P. Veitengruber

Associate Professor

Department of Psychiatry and Behavioral Sciences

University of Washington School of Medicine

Seattle

WA

Divulgaciones

JPV declares that he has no competing interests.

Revisores por pares

Tanveer A. Padder, MD

Chairman

Department of Psychiatry

Trinity School of Medicine

Warner Robins

GA

Divulgaciones

TAP declares that he has no competing interests.

Paul Blenkiron, BM BCh, MA

Consultant Psychiatrist

Leeds and York Partnership NHS Foundation Trust

Bootham Park Hospital

York

UK

Divulgaciones

PB declares that he has no competing interests.

Philip J. Cowen, MD, FRCPsych, FMedSci

Professor of Psychopharmacology

Warneford Hospital

Oxford

UK

Divulgaciones

PJC declares that he has no competing interests.

Toshiaki A. Furukawa, MD, PhD

Professor and Chair

Department of Psychiatry and Cognitive-Behavioral Medicine

Graduate School of Medical Sciences

Nagoya City University

Nagoya

Japan

Divulgaciones

TAF has received research funds and speaking fees from Astellas, Dai-Nippon, Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Meiji, Otsuka, Schering-Plough, and Yoshitomi. He was on a research advisory board for Meiji and Mochida, and is currently on research advisory boards for Sekisui chemicals and Takeda Science Foundation. He has received royalties from Igaku-Shion and Seiwa-Shoten Publishers. The Japanese Ministry of Education, Science, and Technology and the Japanese Ministry of Health, Labor, and Welfare have also funded his research.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision, (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

Andrews G, Bell C, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry. 2018;52(12):1109-172.Texto completo

Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021 Mar 6;397(10277):914-27.Texto completo  Resumen

Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1:S1.Texto completo  Resumen

Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010 May 19;303(19):1921-8. Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Agorafobia
    • Fobias específicas
    • Transtorno da ansiedade social
    Más Diferenciales
  • Guías de práctica clínica

    • Diagnostic and statistical manual of mental disorders: 5th edition, text revision (DSM-5-TR)
    • Generalised anxiety disorder and panic disorder in adults: management
    Más Guías de práctica clínica
  • Folletos para el paciente

    Ansiedade: quais são as opções de tratamento?

    Ansiedade: o que é?

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad